Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aditxt, Inc. (ADTX)
NASDAQ:ADTX
Aditxt, Inc. (ADTX) Stock Price & Analysis
197 Followers
ADTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.14 - $68.08
Previous Close$2.22
Volume21.78K
Average Volume (3M)376.51K
Market Cap
$4.30M
Enterprise Value$21.94M
Total Cash (Recent Filing)$97.10K
Total Debt (Recent Filing)$17.70M
Price to Earnings (P/E)>-0.1
Beta3.70
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-146.46
Shares Outstanding1,665,214
10 Day Avg. Volume74,351
30 Day Avg. Volume376,506
Standard Deviation0.48
R-Squared0.01
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)0.24
Price to Sales (P/S)5.73
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue34.01
Enterprise Value/Gross Profit-196.52
Enterprise Value/Ebitda-0.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aditxt, Inc. News
PremiumCompany Announcements
Aditxt, Inc. Announces Strategic Acquisition of Appili Therapeutics
PremiumCompany Announcements
Aditxt Secures Dawson James for M&A Advisory Role
PremiumCompany Announcements
Aditxt, Inc. CEO’s $205K Loan to Bolster Company Growth
PremiumCompany Announcements
Aditxt, Inc. Faces Defaults and Loan Breaches, Negotiates with Lenders
PremiumCompany Announcements
Aditxt CEO Provides Short-Term Loan to Bolster Stability
PremiumCompany Announcements
Aditxt, Inc. Enters New Financial Obligation Impacting InvestorsRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADTX FAQ
What was Aditxt, Inc.’s price range in the past 12 months?
Aditxt, Inc. lowest stock price was $2.14 and its highest was $68.08 in the past 12 months.
What is Aditxt, Inc.’s market cap?
Currently, no data Available
When is Aditxt, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aditxt, Inc.’s earnings last quarter?
Currently, no data Available
Is Aditxt, Inc. overvalued?
According to Wall Street analysts Aditxt, Inc.’s price is currently Overvalued.
Does Aditxt, Inc. pay dividends?
Aditxt, Inc. does not currently pay dividends.
What is Aditxt, Inc.’s EPS estimate?
Aditxt, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aditxt, Inc. have?
Aditxt, Inc. has 1,961,510 shares outstanding.
What happened to Aditxt, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aditxt, Inc.?
Currently, no hedge funds are holding shares in ADTX
---
Aditxt, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ADTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.97%
12-Months-Change
Fundamentals
Return on Equity
-304.58%
Trailing 12-Months
Asset Growth
315.25%
Trailing 12-Months
Company Description
Aditxt, Inc.
ADiTx Therapeutics Inc is a pre-clinical stage, life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.
---
ADTX Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ADTX
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-93.50%
reiterated a buy rating 8 months ago
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -93.50% per trade.
---